OncLive® Seeks Nominations for 2018 Giants of Cancer Care®

The award celebrates leaders in the field of oncology.

CRANBURY, N.J.--()--OncLive® is now accepting nominations for the 2018 Giants of Cancer Care® awards, which honor medical and scientific experts from the field of oncology who have made strides in cancer research, patient care and clinical practice.

“We are delighted to open up the nominations for the sixth annual Giants of Cancer Care® awards,” said Michael J. Hennessy Jr., president of Michael J Hennessy Associates, the parent company of OncLive®. “Every year, we receive nominations for the most extraordinary medical professionals, who have played a crucial role in the advancement of cancer care.”

Giants of Cancer Care® is a premier event that recognizes individuals who are dedicated to improving the lives of those impacted by cancer. Previous recipients include esteemed medical professionals such as Sir Murray F. Brennan, M.D.; John L. Cameron, M.D.; John M. Kirkwood, M.D.; and Larry Norton, M.D.

The 2018 Giants of Cancer Care® class of inductees will be announced on May 31 by a selection committee of over 90 prominent oncologists.

Nominations are accepted both internationally and domestically. Self-nominations are welcome. For more information and to submit a nomination, visit http://www.giantsofcancercare.com/nominate.

Thanks to our supporters: Bristol-Myers Squibb, Lilly Oncology, Incyte, and AstraZeneca

About OncLive®

A digital platform of resources for practicing oncologists, OncLive.com offers oncology professionals information they can use to help provide the best patient care. OncLive® is the official website for Michael J. Hennessy Associates’ Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News®, Oncology Business Management® and more. Michael J. Hennessy Associates, Inc. is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest US consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.

Contacts

OncLive® Press Contacts:
Theresa Burek, 609-716-7777 ext. 811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com

Contacts

OncLive® Press Contacts:
Theresa Burek, 609-716-7777 ext. 811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com